SARMs strength stack 8 weeks (LGD-4033, S-23)


This stack combines 2 SARMS that have a strong effect on strength.

  • 2 bottles LGD-4033 (Ligandrol) liquid 10mg/ml 30ml
  • 2 bottles S-23 liquid 20mg/ml 30ml
  • Discreet packaging and shipping
  • Guaranteed delivery
  • Free shipping for orders over €200


This SARMs stack combines 2 SARMs that have a powerfull effect on strength.

LGD-4033 (Ligandrol) is a popular SARM among bodybuilders and athletes because it has strong anabolic properties. When compared to anabolic steroids, Ligandrol has relatively few side effects. It is one of the best studied SARMs and is well-known for its ability to help with building muscle.

S-23 is one of the newest SARMs on the market. It is currently being researched as a potential male hormonal contraceptive. But S-23 has many other effects which make it a popular SARM among bodybuilders.

Because of the combination of LGD-4033 and S-23, this stack is highly effective in increasing strength.

LGD 4033 (Ligandrol)

LGD 4033 Ligandrol is the most popular of all the SARMS (Selective Androgen Receptor Modulators). Its effectiveness is well established. Ligandrol is praised for having anabolic effects comparable with AAS (Androgenic Anabolic Steroids), but having fewer side effects because of it’s more tissue-selective method of action.

A quote from the Wikipedia page of Ligandrol:

Ligandrol has been found in World Anti-Doping Agency (WADA) samples and in racehorses too. Like anabolic steroids, it can stimulate muscle growth. “SARMs have shown superior side effect profiles compared with anabolic steroids, which arguably makes them attractive for use by individuals seeking an unfair advantage over their competitors”.


S-23 was developed by GTx. Research has shown S-23 is an orally active non-steroidal SARM, and it has a very high binding affinity to androgen receptors. This makes it one of the strongest SARMs. Research shows that the main effects of S-23 are increased muscle mass, decreased fat mass, and a decrease in the size of the prostate.